Breakthrough Study Reveals Promising Biomarker for Vascular Dementia Prevention and Treatment
A groundbreaking research effort led by Geneva University Hospitals (HUG) and the University of Geneva (UNIGE) has provided fresh insights into age-related dementias, particularly vascular dementia – the second most common form after Alzheimer’s disease. The study spotlights the pivotal role of the brain molecule known as chemokine receptor 5 (CCR5) in the neuronal deterioration…